MSI-H COLORECTAL CANCER
Clinical trials for MSI-H COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MSI-H COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MSI-H COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo shows promise for tough colorectal cancer
Disease control OngoingThis phase II trial is testing whether combining two drugs—niraparib and panitumumab—can help people with advanced colorectal cancer that has spread. The study includes 26 patients whose cancer has not responded to at least one prior treatment. The goal is to see if the combinati…
Matched conditions: MSI-H COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New test could predict immunotherapy success from live tumor samples
Knowledge-focused OngoingThis observational study collects extra tumor tissue from 416 people with various cancers (bladder, kidney, colorectal, head and neck, liver, lung, skin, endometrial) during routine biopsies. The goal is to develop and train a 'live tumor diagnostic platform' that can predict whe…
Matched conditions: MSI-H COLORECTAL CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC